Efficacy of In-Office Treatments for Dentin Hypersensitivity
Study Details
This clinical trial evaluated in-office treatments for dentin hypersensitivity (DH) using different desensitizers: fluoride varnish (Duraphat), bioactive ceramic solution (Biosilicate), universal self-etching adhesive (Single Bond Universal), and bioactive photoactivated varnish (PRG filler).
Findings
The study found that all desensitizers tested were able to reduce initial sensitivity. The bioactive ceramic solution gradually reduced DH after 30 days using computerized analysis.
Practical Solutions and Value
Clinical trials like this one are essential for developing safe and effective treatments. Our AI-driven platform, DocSym, consolidates standards, protocols, and research into an easily accessible knowledge base for clinicians. Streamlining operations with mobile apps for scheduling, monitoring treatments, and telemedicine can improve patient care and expand services digitally. By utilizing AI, clinics can enhance workflows and improve patient outcomes while reducing paper routines.
Learn more about how we can help at aidevmd.com.